Boards

Our Board of Governors, Board of Overseers, and Emeritus Board bring together exceptional leaders across science, medicine, biotechnology, finance, venture capital, and philanthropy—united by a shared commitment to accelerating the development of drugs to prevent, treat, and ultimately cure Alzheimer’s disease.

100% of every donation goes to science. Thanks to the extraordinary generosity of the Lauder family, whose enduring commitment includes underwriting all overhead expenses, your entire donation funds the most innovative Alzheimer's research in the world.

Board of Governors

Strategic Stewardship of Our Mission

The ADDF's distinguished Board of Governors provides strategic stewardship of our mission and reflects the strength of its unique venture philanthropy model. Bringing together leaders across science, medicine, biotechnology, finance, venture capital, and philanthropy, the Board provides the strategic insight, expertise, and global perspective that help drive innovation and advance the next generation of Alzheimer's research.

Chair

Chairman and Co-Founder

Ronald S. Lauder

Chairman, Clinique Laboratories, LLC

Bio

Vice Chairs

Co-Vice Chair and Treasurer

Thomas F. McWilliams

Co-Chair, Mission Related Investment Committee

Private Investor; Retired Managing Partner, Court Square Capital Partners

Bio
Co-Vice Chair and Secretary

Randal Sandler

Chair, Executive Committee Chair, Compensation Committee

Retired Finance Executive; Co-Founder and Partner, FirstGen Content

Bio

Governors

Niranjan Bose, PhD

Managing Director, Health and Life Sciences, Gates Ventures, LLC

Bio

Carol Seabrook Boulanger

Partner, Pillsbury, Winthrop, Shaw, and Pittman, LLP

Roberta Diaz Brinton, PhD

Co-Chair, Scientific Investment Approval Committee

Director, Center for Innovation in Brain Science, University of Arizona Health Sciences; Regents Professor of Pharmacology and Neurology, University of Arizona College of Medicine

Bio

Gavin Cook

Executive Director, Global Alzheimer’s Disease Commercial, Patient Journey and Project Management Head, Eisai US

Bio

Nancy Corzine

President and Chief Executive Officer, Nancy Corzine, Inc.

Bio

David Dolby

Chief Executive Officer, Dolby Family Ventures; Director, Dolby Laboratories; Director, Cogstate Limited; Chief Financial Officer, Ray and Dagmar Dolby Family Fund

Bio

Ric Edelman

Founder, Digital Assets Council of Financial Professionals and Founder, The Truth About Your Future

Bio

Lanny Edelsohn, MD

Neurology Professor Emeritus, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia

Bio

Bonnie Pfeifer Evans

Senior Sales Associate, Corcoran Group Real Estate; Co-Trustee, The Charles Evans Foundation

Bio

Nancy Goodes

Former Executive, Nazareth-Century Mills; Secretary, Melvin R. Goodes Family Foundation, Inc.

Bio

Adam Hoffman

Co-Chair, Mission Related Investment Committee

President, The Foundation For A Better World

Bio

Rachid Izzar

Executive Vice President, Global Product Strategy and Commercialization, Biogen, Inc.

Bio

Ann Jackson

Philanthropist

Bio

Miia Kivipelto, MD, PhD

Professor of Clinical Geriatrics, Karolinska Institutet Center for Alzheimer Research; Senior Geriatrician and Director for Research and Development of Medical Unit Aging, Karolinska University Hospital

Bio

Gary M. Lauder

Managing Director, Lauder Partners LLC

Bio

Bonnie Lautenberg

Photographer and Writer, Bonnie Lautenberg Designs

Laurence C. Leeds, Jr.

Former Chairman, Buckingham Capital Management, Inc.

Bio

Richard C. Mohs, PhD

Co-Chair, Scientific Investment Approval Committee

Chief Science Officer, Global Alzheimer’s Platform Foundation

Bio

Sharon T. Sager, CIMA

Co-Chair, Finance and Audit Committee

Managing Director and Private Wealth Advisor, UBS Private Wealth Management

Bio

Philip Scheltens, MD, PhD

Partner & Head of the Dementia Fund, EQT Group, Amsterdam

Bio

Julieann Shanahan, CFA

Co-Chair, Finance and Audit Committee

Creator, Pavilion Living: Architecture, Patronage and Well-Being

Alice Shure

Founder and Producer, AMICI Productions LLC; Co-Trustee, The Charles Evans Foundation

Bio

Anthony (Nino) Sireci, MD

Sr. Vice President, Clinical Biomarkers, Laboratories and Diagnostics, Eli Lilly and Company

Thomas S. (Tad) Smith, Jr

Chief Executive Officer, Durable Money LLC; Supervisory Board Chairman, The Fine Art Group

Bio

David R. Weinreb

Chief Executive Officer, Weinreb Ventures

Bio

Paula Zahn

Host and Executive Producer, Discovery ID's "On the Case with Paula Zahn," and WNET's "NYC Arts"

Bio

Henrik Zetterberg, MD, PhD

Professor of Neurochemistry and Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg and Clinical Chemist at Sahlgrenska University Hospital

Bio

Board of Overseers

Champions of Our Work

The ADDF’s Board of Overseers brings together a dynamic group of leaders across science, philanthropy, and business who are dedicated to advancing the foundation's mission. Through their expertise and partnership, members help expand the ADDF's network, deepen engagement with our work, and champion efforts to bring new treatments and diagnostics to patients faster.

Chair

Chair, Board of Overseers

Christopher Johnson

President, Rackson Companies

Overseers

Bal Agrawal

Founder and Chief Executive Officer, LifeWorx, Inc.; Founder and Chief Executive Officer, Prima Chefs, Inc.

Charles Cangro

Former Principal, Personal Financial Services, Ernst & Young, LLP

Kristin Rae Cecchi

Marketing Design Consultant, Cecchi Homes

Charlie Lefkowitz Crowley

Educational Consultant and Philanthropist

Mitchell D. Eichen, J.D., LL.M.

Former Founder and Chief Executive Officer, Acertus Capital Management; Former Founder and Chief Executive Officer, The MDE Group

Phyllis Ferrell

Chief Impact Officer, Alzheimer's Moonshot, StartUp Health; Senior Consultant, Gates Ventures, LLC; Independent Advisor, PBFerrell, LLC

Joel Florin

President, Micro Essential Laboratory, Inc.

Gina F. Fochetta

Executive Director, J.P. Morgan Private Bank; Co-Founder and Co-Chair, ADDF Young Professionals Committee

Dave Gerson

Personal Financial Planning Consultant, Retired Tax Partner Ernst & Young, LLC

Stephanie Ginsberg

Volunteer, Philanthropist; Founder, BCRF Pink Promises Benefit

Allan M. Green, MD, PhD, JD

Allan M. Green Esq., LLC

Mitchell Kaneff

Chairman and Chief Executive Officer, Arkay

Josh Lauder

Co-Founder and Co-Chair, ADDF Young Professionals Committee

Elise Gelman Lefkowitz

Philanthropist

Philip Lovett

Founding Partner, Millennium Partners

Julie Medler

Retired Managing Director, JPMorgan

Justin Meltzer

Real Estate Operations, DLA Piper LLP

Phebe Farrow Port

Senior Vice President, Global Management Strategies, and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies, Inc.

Gregory A. Rosica

Retired Partner, Tax, Ernst & Young, LLP

Tom Scanlan

Partner, Spencer Stuart

John H. Scully, CIMA

Senior Managing Director and Head of Private Wealth Advisory, Nuveen Investments

Stephen Toma

Investor and Philanthropist

Wendy L. Wilshin

Founder and Principal, WLW Designs

Emeritus Board of Directors

Enduring Leadership & Legacy

The ADDF recognizes these distinguished individuals for their longstanding service and leadership. As emeritus members, they remain valued champions of the foundation’s mission and of the vision that has shaped the ADDF’s leadership in Alzheimer’s research.

Governors in Memoriam

Chairman Emeritus and Co-Founder • In Memoriam

Leonard A. Lauder

Chairman Emeritus, The Estée Lauder Companies Inc.

Bio
In Memoriam

Melvin R. Goodes

Former Chairman and Chief Executive Officer, Warner-Lambert

Bio
In Memoriam

Justice Sandra Day O'Connor

Associate Justice, US Supreme Court

Bio

Honorary Governors

Co-Founder and Chief Science Officer Emeritus

Howard Fillit, MD

Bio
Honorary Member

Robert A. Belfer

Chairman Emeritus, Belfer Management LLC

Bio
Honorary Member

Sally Susman

Executive Vice President, Policy, External Affairs and Communications, Pfizer Inc

Bio